Victory Capital Management Inc. Sells 18,358 Shares of Azenta, Inc. (NASDAQ:AZTA)

Victory Capital Management Inc. reduced its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 67.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,923 shares of the company's stock after selling 18,358 shares during the quarter. Victory Capital Management Inc.'s holdings in Azenta were worth $446,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of AZTA. Ballentine Partners LLC raised its holdings in shares of Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after buying an additional 404 shares in the last quarter. Glenmede Trust Co. NA boosted its stake in Azenta by 6.3% in the third quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock worth $551,000 after buying an additional 679 shares in the last quarter. KBC Group NV grew its position in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after acquiring an additional 698 shares during the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of Azenta by 7.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after acquiring an additional 702 shares in the last quarter. Finally, Quest Partners LLC lifted its holdings in shares of Azenta by 31.5% in the 3rd quarter. Quest Partners LLC now owns 7,941 shares of the company's stock worth $385,000 after acquiring an additional 1,902 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of brokerages recently commented on AZTA. Stephens reiterated an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th. Needham & Company LLC boosted their target price on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Finally, Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Azenta has a consensus rating of "Hold" and an average price target of $58.75.

Azenta Stock Down 1.3 %

Shares of NASDAQ:AZTA traded down $0.51 during midday trading on Tuesday, hitting $37.72. 23,664 shares of the stock traded hands, compared to its average volume of 585,142. The business's 50 day moving average is $46.42 and its two-hundred day moving average is $46.57. The stock has a market capitalization of $1.72 billion, a PE ratio of -12.62 and a beta of 1.52. Azenta, Inc. has a one year low of $35.56 and a one year high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.